The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
26-Jun-24
Pending
$630 million
Target:
Haleon plc’s Nicotine Replacement Therapy Business (ex-US)
![India India flag](https://www.greenhill.com/sites/default/files/india.gif)
Acquiror:
Dr. Reddy’s Laboratories
Advising Haleon plc on the sale of its global nicotine replacement therapy business (ex-US) to Dr. Reddy’s Laboratories
15-Dec-19
$45.4 billion
![](https://www.greenhill.com/sites/default/files/new_project_0.png)
Target:
Nutrition & Biosciences Division of DuPont de Nemours, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Acquiror:
International Flavors and Fragrances, Inc.
Advising IFF, a global leader in flavors and fragrances, on its merger with DuPont’s Nutrition & Biosciences Division, creating a clear global leader in the specialty ingredients sector
03-May-07
$8.5 billion
![USA/Canada U.S.A., Canada flags](https://www.greenhill.com/sites/default/files/usa_canada.gif)
Target:
IPSCO Inc.
![Sweden Sweden flag](https://www.greenhill.com/sites/default/files/sweden.gif)
Acquiror:
SSAB Svenskt Stål AB
Acted as lead financial advisor to SSAB Svenskt Stål AB on its acquisition of IPSCO Inc., a leading Canadian producer of energy tubulars and steel plate in North America with an annual steel making capacity of 4.3 million tons